Resveratrol protects against deoxynivalenol-induced ferroptosis in HepG2 cells
Authors:
- 5 July 2023
- journal article
- research article
- Published by Elsevier in Toxicology
- Vol. 494, 153589
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Development of in vitro 3D cell model from hepatocellular carcinoma (HepG2) cell line and its application for genotoxicity testingArchives of Toxicology, 2019
- Resveratrol alleviates chemotherapy-induced oogonial stem cell apoptosis and ovarian aging in miceAging, 2019
- EGR1 is essential for deoxynivalenol-induced G2/M cell cycle arrest in HepG2 cells via the ATF3ΔZip2a/2b-EGR1-p21 pathwayToxicology Letters, 2018
- Protection of Porcine Intestinal-Epithelial Cells from Deoxynivalenol-Induced Damage by Resveratrol via the Nrf2 Signaling PathwayJournal of Agricultural and Food Chemistry, 2018
- Tissue iron quantification in chronic liver diseases using MRI shows a relationship between iron accumulation in liver, spleen, and bone marrowClinical Radiology, 2018
- Resveratrol alleviates FFA and CCl4 induced apoptosis in HepG2 cells via restoring endoplasmic reticulum stressOncotarget, 2017
- Upgrading HepG2 cells with adenoviral vectors that encode drug-metabolizing enzymes: application for drug hepatotoxicity testingExpert Opinion on Drug Metabolism & Toxicology, 2016
- Protective Capacity of Resveratrol, a Natural Polyphenolic Compound, against Deoxynivalenol-Induced Intestinal Barrier Dysfunction and Bacterial TranslocationChemical Research in Toxicology, 2016
- Resveratrol ameliorates lipid accumulation in HepG2 cells, associated with down-regulation of lipin1 expressionCanadian Journal of Physiology and Pharmacology, 2016
- Effects of the mycotoxin deoxynivalenol on human primary hepatocytesMolecular Nutrition & Food Research, 2008